Function and Mechanism of Small Nucleolar RNAs (snoRNAs) and Their Host Genes (SNHGs) in Malignant Tumors
Biomolecules · 19.11.2025 · 15 (11) · 1625
DOI: 10.3390/biom15111625 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 19.11.2025. Verfasst von Jiaji Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Changzhou Medical Center, Nanjing Medical University, 185 Juqian Street, Changzhou 213003, China. Hauptthemen laut MEDLINE: RNA, Small Nucleolar, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and technology project of Changzhou Health Commission, Leading Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project, Top Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project.
Abstract (Originalsprache)
Small nucleolar RNAs (snoRNAs) and their host genes (SNHGs) are non-coding RNAs that are integral to tumorigenesis and progression. snoRNAs contribute to tumor progression primarily through RNA modification and engagement in intracellular signaling, and by serving as precursors for small nucleolar RNA-derived RNAs (sdRNAs) that exert microRNA (miRNA)-like or epigenetic regulatory functions. SNHGs modulate key tumor cell behaviors—including proliferation, metastasis, and resistance to therapy—through competing endogenous RNA (ceRNA)-mediated interactions and epigenetic mechanisms. Their combined influence significantly impacts patient prognosis. Across diverse malignancies such as neurologic, bone, and head and neck cancers, snoRNAs and SNHGs exhibit cancer-specific regulatory dynamics; for instance, in glioblastoma, snoRNAs and their derived fragments (sdRNAs) contribute to intratumoral heterogeneity by mediating both metabolic reprogramming and epigenetic remodeling, while their mediated modulation of cellular proliferation and metastatic potential is evident in breast cancer. Concurrently, several snoRNAs and SNHGs have emerged as potential diagnostic and prognostic biomarkers, as well as therapeutic targets. Preclinical interventions targeting select snoRNAs or SNHGs have demonstrated promising therapeutic outcomes. This study reviews current insights into the oncogenic functions and signaling networks associated with dysregulated snoRNAs and SNHGs in malignancies, while highlighting novel avenues for future investigation in this domain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Changzhou Medical Center, Nanjing Medical University, 185 Juqian Street, Changzhou 213003, China.
- Department of Radiation Oncology, The First People's Hospital of Changzhou, Changzhou 213003, China.
ORCID-Profile: Wendong Gu
Förderung
- Science and technology project of Changzhou Health Commission
- Leading Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project
- Top Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project
- Changzhou Key Medical Discipline
- Science and Technology Bureau foundation application project of Changzhou
Zitieren
APA
Yu, J., Shao, Y., & Gu, W. (2025). Function and Mechanism of Small Nucleolar RNAs (snoRNAs) and Their Host Genes (SNHGs) in Malignant Tumors. Biomolecules, 15(11), 1625. https://doi.org/10.3390/biom15111625
Vancouver
Yu J, Shao Y, Gu W. Function and Mechanism of Small Nucleolar RNAs (snoRNAs) and Their Host Genes (SNHGs) in Malignant Tumors. Biomolecules. 2025;15(11):1625. doi:10.3390/biom15111625
BibTeX
@article{Yu2025,
author = {Yu, Jiaji and Shao, Yingjie and Gu, Wendong},
title = {Function and Mechanism of Small Nucleolar RNAs (snoRNAs) and Their Host Genes (SNHGs) in Malignant Tumors},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {11},
pages = {1625},
doi = {10.3390/biom15111625}
}
EUVIMED